Yu Lu, Dong Yin, Li Mincheng, Liu Huifang, Yan Cuina, Li Xiaoxian, Gu Yuehua, Wang Liwei, Xu Chuan, Xu Jie, Yuan Zhen, Xia Ming, Cheng Jiwei
Comprehensive Department of Traditional Chinese Medicine, Department of Neurology, First Department of Integration, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Neurology, Shanghai Jinshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.
Front Cell Dev Biol. 2025 Jun 10;13:1580479. doi: 10.3389/fcell.2025.1580479. eCollection 2025.
Given that ischemic stroke ranks as one of the most fatal diseases globally, it is imperative to develop clinically effective neuroprotective agents for stroke. Microglia serve as innate immune cells for maintaining brain homeostasis, and upon activation, they are well-known to be able to transform into two functional phenotypes, namely, the M1 and M2 types, which can convert each other and exert opposing effects on neurotoxicity and neuroprotection, respectively. Traditional Chinese medicine possesses a deep-rooted and profound history with rich theory in treating cerebrovascular disorders, and its natural compounds have been considered as promising adjunctive therapies. Recently, researchers have been devoting attention to the inflammation-suppressive properties of the compounds from Chinese herbs. These compounds are gradually emerging as adoptable therapeutic agents with wide application prospect for improving stroke outcomes, through regulating microglial polarization to attenuate neuroinflammation. Thereby, we reviewed the functions of microglial cells in inflammation and neuroprotection and explored the regulation of microglial activity by natural compounds to alleviate neuroinflammation and protect neural function after ischemic stroke. Collectively, using natural compounds to suppress the microglia-mediated detrimental inflammatory response, meanwhile enhancing their anti-inflammatory abilities to accelerate neuronal recovery, will be promising therapeutic approaches for ischemic stroke.
鉴于缺血性中风是全球最致命的疾病之一,开发临床上有效的中风神经保护剂势在必行。小胶质细胞作为维持脑稳态的固有免疫细胞,激活后,众所周知它们能够转变为两种功能表型,即M1型和M2型,它们可以相互转化,并分别对神经毒性和神经保护发挥相反的作用。中医在治疗脑血管疾病方面有着悠久而深厚的历史和丰富的理论,其天然化合物被认为是有前景的辅助疗法。最近,研究人员一直关注中草药化合物的抗炎特性。这些化合物正逐渐成为具有广泛应用前景的可采用治疗剂,通过调节小胶质细胞极化来减轻神经炎症,从而改善中风预后。因此,我们综述了小胶质细胞在炎症和神经保护中的功能,并探讨了天然化合物对小胶质细胞活性的调节作用,以减轻缺血性中风后的神经炎症并保护神经功能。总的来说,使用天然化合物抑制小胶质细胞介导的有害炎症反应,同时增强其抗炎能力以加速神经元恢复,将是缺血性中风有前景的治疗方法。